3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
1
Interventions
Gemcitabine
13
Radiotherapy
12
Androgen Antagonists
12
Specimen Handling
9
Magnetic Resonance Spectroscopy
9
pembrolizumab
8
toripalimab
7
darolutamide
7
Nivolumab
7
Drug Therapy
7
Docetaxel
7
Radiosurgery
6
Cystectomy
6
enzalutamide
5
apalutamide
5
abiraterone
5
Mitomycin
5
Cisplatin
5
Abiraterone Acetate
5
disitamab vedotin
4
Pluvicto
4
Cyclophosphamide
4
Axitinib
4
tislelizumab
3
fludarabine
3
enfortumab vedotin
3
cemiplimab
3
cabozantinib
3
Sunitinib
3
Standard of Care
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
RC48 antibody
×
Genitourinary
×
Clear all
NCT07608224
2026-05-27
HOPE-07-MIBC
West China Hospital
Phase 2/3
Not yet recruiting
240 enrolled